Pharmaceutical giant Pfizer has reached a settlement agreement in an antitrust lawsuit related to its cholesterol-lowering drug Lipitor. Under the terms of the agreement, Pfizer will pay a total of $93 million to resolve the claims against the company.
The lawsuit, which was filed in 2014, alleged that Pfizer engaged in unfair business practices to delay the entry of generic versions of Lipitor into the market. Lipitor, a widely prescribed medication for managing high cholesterol, was once the world's best-selling drug.
